Marine-derived Pharmaceuticals Market Size, Share, Growth Report, Forecast 2030

According to the report published by Zion Market Research, the global Marine-Derived Pharmaceuticals Market size was valued at USD 2,561.47 Million in 2022 and is predicted to reach USD 4,316.97 Million by the end of 2030. The market is expected to grow with a CAGR of 7.74% during the forecast period.

Request Free Sample

The report analyzes the global Marine-Derived Pharmaceuticals Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Marine-Derived Pharmaceuticals Industry.

Global Marine-Derived Pharmaceuticals Market: Overview

Marine life has become an essential source of therapeutic drugs with a novel mechanism. Marine-derived pharmaceuticals are a rich source of chemical varieties that offer the development of potentially useful pharmaceuticals. Few marine-derived drugs are approved by concerned authorities. However, unexplored marine life is emerging as an area of high interest to the pharmaceutical industry and biotechnologists due to the fact that it contains an abundance of pharmacology technology that can be very useful for the development of several useful drugs.

However, only a few of the discovered marine organisms are approved as potential resources for drugs and therapeutics. Some of them are soft corals, sea fans, and sponges. Nowadays, several advancements have been made in the lab globally for researching potential marine technologies that can help in the treatment of life-threatening diseases like AIDS and cancer.

Request Free Sample

Global Marine-Derived Pharmaceuticals Market: Growth Factors

Rising incidences of several chronic diseases have emerged as a primary concern for health authorities globally. Governments are investing huge funds for developing advanced solutions to lower the rising burden of chronic ailments on health infrastructure. However, many studies have concluded that marine organisms are high-quality resources offering effective solutions for many life-threatening ailments like Alzheimer's diseases, Harper’s, cancer, and others.

Such a landscape along with a growing success rate is one of the major factors driving the growth of the global marine-derived pharmaceuticals market. Some of the marine organisms that are currently being used for deriving therapeutic drugs include tunicates, deep-sea bacteria, mollusk, and sponges.

The surge in ethanol preparation for exploring automated pharmacological bioassays will offer ample thrust to the growth of the market. Polyunsaturated fatty acids including docosahexaenoic and eicosapentaenoic acid are some of the applications in marine pharmacology. Marine biotechnology is transforming, catering to the growing prevalence of unmet medical requirements of pharmaceutical products. However, the expectation of potential pipeline drugs including anticancer therapeutics is likely to hold immense growth prospects in the global marine-derived pharmaceuticals market in forthcoming years.

The launch of new-age technological advancements along with intense research and development activities in the area of marine exploration especially in highly industrialized markets is likely to support the growth of the market. However, there is significant growth in the inclination of professionals toward marine life research to innovate effective therapeutic drugs.

Lucrative growth opportunity in marine pharmacy is likely to expand globally due to the growing awareness among developing countries having a large number of marine resources, including Brazil, Maldives, and Thailand. Also, rising initiatives to preserve marine biodiversity are further creating opportunities in the market globally. However, the growing demand for pharmaceutical products extracted from natural resources will support the growth of the global marine-derived pharmaceuticals market.

Global Marine-derived Pharmaceuticals Market Report Scope:

Global Marine-Derived Pharmaceuticals Market: Segmentation

The global marine-derived pharmaceuticals market can be segmented into end-user, mode of delivery, source, type, and region.

By end-user, the market can be segmented into online pharmacy, retail pharmacy, hospitals, and others.

By mode of delivery, the market can be segmented into anti-inflammatory, antiviral, anti-cardiovascular, antitumor, antimicrobial, and others. The antitumor drug segment holds domination over others due to its growing utilization in treating cancer. Furthermore, antitumor drugs are preferred as they help in treating the problems of several other chronic diseases also.

By source, the market can be segmented into microorganisms, invertebrates, algae, and others. The invertebrates segment accounts for the largest share in the global marine-derived pharmaceuticals market as it is one of the major groups of organisms used in the drug development process. Furthermore, marine invertebrates like crustaceans and mollusks are associated with many medicinal benefits which can help in enhancing human health.

By type, the market can be segmented into tunicates, sponge, mollusk, peptide, ethers, steroid, phenol, and others.

Global Marine-Derived Pharmaceuticals Market: Regional analysis

North America accounts for the largest share in the global marine-derived pharmaceuticals market due to the growing investments in marine pharmacology in the region by both the federal government and private entities. The growing awareness among people regarding leveraging the marine diaspora for the drug development process will also accentuate the growth of the regional market. Also, the high prevalence of chronic diseases like cancer and several infectious diseases in the region will also pose huge demand for marine pharmacology.

Asia Pacific is expected to grow with a high CAGR in forthcoming years due to the fast proliferating pharmaceutical sector in the region. Also, the ongoing technological advancements in the field of marine micro biotechnology will further promulgate the growth of the regional market.

Global Marine-Derived Pharmaceuticals Market: Competitive Players

Some of the significant players in the global marine-derived pharmaceuticals market are: 

• Sanofi S.A.
• Aphios Corporation
• Sea Run Holdings Inc.
• Aker BioMarine AS
• Abbvie Inc
• GlaxoSmithKline PLC
• Pharma Marine USA
• LLC
• Takeda Oncology’s Millennium
• Bayer Innovation Marine Polymer Technologies Inc.
• Abbott Laboratories.

The Global Marine-Derived Pharmaceuticals Market: Segmentation

By End-user:

• Online Pharmacy
• Retail Pharmacy
• Hospitals
• And Others

By Mode Of Delivery:

• Anti-inflammatory
• Antiviral
• Anti-cardiovascular
• Antitumor
• Antimicrobial
• Others

By Source:

• Microorganisms
• Invertebrates
• Algae
• And Others

By Type: 

• Tunicates
• Sponge
• Mollusk
• Peptide
• Ethers
• Steroid
• Phenol
• Others

By Region:

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.